CA-YUBICO
6.5.2024 15:01:34 CEST | Business Wire | Press release
Today Yubico (NASDAQ: YUBICO), the leading provider of hardware authentication security keys, announced the upcoming release of YubiKey 5.7 firmware for the YubiKey 5 Series, Security Key Series and Security Key Series - Enterprise Edition. With a focus on enterprise needs, these updates reinforce Yubico’s commitment to providing secure, simple, and scalable authentication solutions. Security keys with firmware 5.7 will be available to purchase in late May 2024, offering enhanced features such as improved PIN complexity, enterprise attestation, and expanded passkey credentials storage. These updates empower organizations to adopt passwordless-first, modern authentication, fostering phishing-resistant users worldwide.
As part of Yubico’s goal of helping enterprises raise the bar for security with greater flexibility, the company also announced the availability of Yubico Authenticator 7 which will support the upcoming YubiKey 5.7 features.
“Organizations are continuing to face a surge in the variety and complexity of cyber threats at historical rates, often fueled by compromised employee login credentials, frequently resulting from attacks such as phishing. This trend is exacerbated by the rise in use of Artificial Intelligence (AI),” said Jeff Wallace, senior vice president of product at Yubico. “We’re excited to continue offering best-in-class solutions that protect organizations and accelerate their transition to passwordless with the latest enterprise-focused updates to the YubiKey. We’re confident that organizations are now better equipped than ever to enforce compliance requirements and elevate their security posture throughout their organization.”
YubiKey 5.7: Accelerating enterprises to passwordless
To help organizations tackle this challenge, Yubico’s key updates and enhancements to the YubiKey 5 Series and Security Key Series* include:
-
Enhanced PIN complexity across all YubiKey applications
- Block simple patterns and common PINs at the hardware level to enable compliance with upcoming NIST requirements and corporate mandates. This includes FIDO2, PIV, and OpenPGP.
-
Enterprise attestation
- Allow organizations to enforce the usage of YubiKeys that they purchased via custom programmed keys with enterprise attestation. Working in conjunction with identity providers, this capability can also facilitate the retrieval of unique identifiers during FIDO2 registration to streamline asset tracking and account recovery.
-
FIDO2 enhancements
- Empower organizations to enforce compliance requirements and elevate security measures surrounding PIN usage. YubiKey 5.7 implements FIDO Client-to-Authenticator Protocol (CTAP) 2.1, embracing the latest FIDO2 protocol features such as Force PIN Change and Minimum PIN Length.
-
Expanded passkey and passwordless storage
- Provide ample storage space to meet authentication needs while maintaining strong security standards. More storage for FIDO2 discoverable credentials (passkeys) and OATH one-time passwords will now accommodate up to 100 passkeys, 24 PIV certificates, 64 OATH seeds, and 2 OTP seeds at once for a total of 190 credentials.
-
Expansion and enhancement of public key algorithms for PIV applications
- Align with DoD memo requirements and offer advanced key management functions, enhancing flexibility for organizations through support of larger RSA keys (RSA-3072 and RSA-4096), as well as Ed25519 and X25519 key types.
-
Migration to Yubico’s own cryptographic library
- Yubico has developed a library in-house that performs the underlying cryptographic operations (decryption, signing, etc.) for RSA and ECC.
“The new features within 5.7 allow enterprises to streamline critical processes such as asset tracking and account recovery, while also enhancing flexibility,” said Wallace. “These updates empower enterprises with the latest authentication advancements and tools to build specific strategies for creating phishing-resistant users and mitigating phishing threats for employees, external identities, and customers.”
Capabilities in the new 5.7 YubiKeys also align with recent U.S. Government memo requirements on adopting phishing-resistant MFA and offer advanced key management functions. Compliance with upcoming NIST requirements and corporate mandates is also supported by enforcing the blocking of simple patterns and common PINs at the hardware level.
*Note: Smart Card/PIV capabilities, OATH and OTP credentials are not available on any Security Key Series thus these updates are not applicable. Enterprise attestation is available on the YubiKey 5 Series and Security Key Series - Enterprise Edition. See here for more details.
Yubico Authenticator 7: Hardware-backed authenticator app across desktop and mobile
Aligned with the 5.7 firmware release, significant updates within Yubico Authenticator 7 launched today in support of managing these new features. This new version enables use of the new public key algorithms for PIV, bringing more advanced management options and streamlines the interface for a better user experience when handling many credentials. Additionally, it adds localization with official support for French and Japanese, with additional community-provided translations. The app is now available for all major desktop platforms, as well as for Android. Enhanced features for iOS will be coming in the next version of the iOS application. It's the perfect companion to the new YubiKey 5.7, with its expanded credential storage.
The Yubico Authenticator delivers strong security by enabling users to store credentials on a YubiKey instead of a mobile phone, thereby significantly removing risks posed by remote attackers targeting software-based authenticator apps. By incorporating hardware-backed strong two-factor authentication in the YubiKey, credentials stays safe and the bar for security is raised while delivering the convenience of an authenticator app.
For more information on today’s innovation announcements from Yubico, visit here. To get the Yubico Authenticator 7 app, visit here.
About Yubico
Yubico (Nasdaq First North Growth Market Stockholm: YUBICO), the inventor of the YubiKey, offers the gold standard for phishing-resistant multi-factor authentication (MFA), stopping account takeovers in their tracks and making secure login easy and available for everyone. Since the company was founded in 2007, it has been a leader in setting global standards for secure access to computers, mobile devices, servers, browsers, and internet accounts. Yubico is a creator and core contributor to the FIDO2, WebAuthn, and FIDO Universal 2nd Factor (U2F) open authentication standards, and is a pioneer in delivering modern, hardware-based passkey authentication security at scale to customers in over 160 countries.
Yubico’s solutions enable passwordless logins using the most secure form of passkey technology. YubiKeys work out-of-the-box across hundreds of consumer and enterprise applications and services, delivering strong security with a fast and easy experience.
As part of its mission to make the internet more secure for everyone, Yubico donates YubiKeys to organizations helping at-risk individuals through the philanthropic initiative, Secure it Forward. The company is headquartered in Stockholm and Santa Clara, CA. For more information on Yubico, visit us at www.yubico.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240506185894/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
